Author: Odland, J.
Title: Society for immunotherapy of cancer's (sitc) 35th annual meeting Cord-id: frvh8n90 Document date: 2021_1_1
ID: frvh8n90
Snippet: Participants from industry and academia attended the 35th Society for Immunotherapy of Cancer (SITC) Annual Meeting held over November 9-14, 2020. SITC 2020 was originally scheduled to be held in Washington, D.C., but due to public health concerns surrounding the SARS-CoV-2 (COVID-19) pandemic, it was instead presented as a virtual summit. The SITC 2020 program was organized in several sections: Biomarkers, immune monitoring and novel technologies;cellular therapies;checkpoint blockade therapy;c
Document: Participants from industry and academia attended the 35th Society for Immunotherapy of Cancer (SITC) Annual Meeting held over November 9-14, 2020. SITC 2020 was originally scheduled to be held in Washington, D.C., but due to public health concerns surrounding the SARS-CoV-2 (COVID-19) pandemic, it was instead presented as a virtual summit. The SITC 2020 program was organized in several sections: Biomarkers, immune monitoring and novel technologies;cellular therapies;checkpoint blockade therapy;combination immunotherapies;COVID-19 and immunotherapy;immune cell biology;immune cell types, immune-stimulants and immune modulators;immunoconjugates and chimeric molecules;immunotherapy toxicities;machine learning, artificial intelligence and computational modeling;microbiome and other environmental factors;novel single-agent immunotherapies;and tumor and stromal cell biology. This report highlights some of the presentations across these streams over the course of the meeting. © 2021 Clarivate Analytics.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date